Optimization Through AI Vision
AI Vision for the Operating Room & Cell & Gene Therapy
Computer vision and AI that streamline surgical workflows, eliminate instrument redundancy, and automate CGT manufacturing.
Computer vision and AI that streamline surgical workflows, eliminate instrument redundancy, and automate CGT manufacturing.
Trusted Academic & Research Partners
The Problem
Hospitals and CGT manufacturers face mounting cost pressures from labor-intensive workflows.
Bloated trays, misplaced instruments, and poor data sharing between OR and SPD inflate costs and delay procedures.
Manual processes and bioreactor constraints remain cost prohibitive, limiting patient access.
SPD-OR Platform
AI cameras that transform instrument tracking, tray composition, and OR turnover.
Our AI classifies every instrument in the tray, tracks utilization, flags redundancies, and recommends optimized sets.
At TJUH, we reduced a TLIF set from 100 to 40 instruments — 60% reduction, zero compromise in surgical capability.
Real-time visibility on every instrument throughout each procedure.
Identify instruments that rarely leave the tray. Evidence-based optimization.
Each additional tray adds 3 min to turnover. Streamlined sets cut idle time and maximize OR throughput.
Instrument verification, bioburden detection, and case data for SPD operators.
RFID tagging plus computer vision: a closed-loop ecosystem for 100% visibility.
At $5,000/surgeon/month, the platform delivers $400K in annual savings.
Bodhi
Suspension cell techniques cost $1M per patient. Bodhi's AI-guided automation dramatically reduces costs and scales access to therapies.
Automated cell culture inspection monitors development in real time, reducing manual intervention.
Precision multi-step manufacturing via our automated multi-layered 2D concentric roller bottle platform.
HEK-293-based production with fit-to-spec vector design, serotype selection, and optimized yields.
An automated roller bottle system for adherent AAV production. Real-time monitoring, automated feeding, and environmental control in a compact form factor.
Scale-up that aligns research with commerical manufacturing.
Self-contained platform available in 3 x 3 and 5 x 5 profiles.
Our fully integrated pipeline covers every stage of AAV production.
We preserve adherent biology, add automation, and scale out — without the drawbacks of bioreactors or microcarrier systems.
Mirrors discovery SOP. Multi-layer concentric bottles preserve process fidelity at scale.
Full visual access for AI monitoring. High full/empty capsid ratio. Segmented bottles isolate failures.
Low early-phase capex. Reproducible yields with high batch comparability.
Tailored conditions per bottle to optimize growth across runs.
Research Partnerships
Based at the Babraham Research Campus, Cambridge, UK. Collaborating with leading academic centres to bring AI innovation to clinical practice.
Clinical validation: turnover metrics, instrument burden analysis, and tray optimization across neurosurgical and ENT specialties.
NIH SBIR partnership: Automated 2D Cell & Gene Therapy Manufacturing Platform.
Publications & Research
Selected publications from our team spanning AI-driven surgical analytics, gene therapy, and neural regeneration.
Full publication list (26+ papers) available on ResearchGate.
In the News
The latest from the world of surgical AI, gene therapy, and regenerative medicine.
Team
Neurosurgery, AI, gene therapy, and commercialization under one roof.
Chief Executive Officer
Chief Technology Officer
Chief Operating Officer
Chief Scientific Officer
Director Clinical Strategy
Director Medical Sales
Advisor
Contact
Hospital administrators, CGT manufacturers, academic partners — we'd like to hear from you.
